Crossmark

Efficacy and safety of interferon-alpha 1b combined with PD-1 monoclonal antibody in patients with unresectable stage IV melanoma: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s00432-023-04596-3

Published Online: 2023-01-30

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Guannan

Shi, Qiong

Zhao, Bolun

Liu, Yu

Feng, Ting

Li, Chunying

Gao, Tianwen
License Information

Text and Data Mining valid from 2023-01-30

Version of Record valid from 2023-01-30
More Information

Article History

Received: 23 November 2022

Accepted: 21 January 2023

First Online: 30 January 2023

Declarations

:

: The authors have no conflict of interest to disclose.

Document is current

Any future updates will be listed below